Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard
Fierce Pharma
DECEMBER 13, 2022
Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard. aliu. Tue, 12/13/2022 - 20:12.
Fierce Pharma
DECEMBER 13, 2022
Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard. aliu. Tue, 12/13/2022 - 20:12.
Copyright Clearance Center
DECEMBER 13, 2022
December 13, 20 22 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has been named one of the Top Places to Work in Massachusetts in the 15 th annual employee-based survey project from The Boston Globe. CCC ranked #17, up from #33 last year, in the “ large companies ” category (organizations between 250-999 employees).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 13, 2022
Eli Lilly says 4 new launches will help drive its 2023 revenue past $30B. zbecker. Tue, 12/13/2022 - 12:29.
MedCity News
DECEMBER 13, 2022
The majority of health systems now offer some sort of home-based care program, according to a new survey of hospital leaders. The biggest goals of these programs are to improve patient outcomes through reductions in readmissions, hospitalizations and emergency room visits, the report found.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
DECEMBER 13, 2022
Evonik backs Allay's development of post-surgery pain therapy implants. ntaylor. Tue, 12/13/2022 - 10:32.
MedCity News
DECEMBER 13, 2022
CMS hopes the changes will increase healthcare access for underserved populations, streamline the plan selection process and simplify enrolling in Marketplace coverage.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 13, 2022
Amgen’s Lumakras became the first FDA-approved drug that addresses the elusive KRAS mutation, but Mirati believes its newly approved therapy, Krazati, could be better. The small molecule’s features include the ability to penetrate into the brain, where it can address cancer that has spread to the central nervous system.
Fierce Pharma
DECEMBER 13, 2022
Recovering from rejection, Eyenovia lands May FDA decision date for eye spray. ntaylor. Tue, 12/13/2022 - 09:55.
MedCity News
DECEMBER 13, 2022
This summer, Adventist Health began a three-year partnership with Emcara Health, a primary care provider group that deploys community health workers into the places people live. Five months later, Emcara is saying that the program is seeing significant engagement and improving patients’ ability to keep up with their care plan.
Fierce Pharma
DECEMBER 13, 2022
After Vifor acquisition and gene therapy approval, CSL taps McKenzie as its next CEO. kdunleavy. Tue, 12/13/2022 - 09:25.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
DECEMBER 13, 2022
About 62% of Americans don’t trust their health plan when it comes to finding care, a Ribbon Health survey found. Providing more accurate information on provider directories could repair this trust.
Fierce Pharma
DECEMBER 13, 2022
SHL, after bagging long-term contracts, lands financial support for drug delivery growth strategy. ntaylor. Tue, 12/13/2022 - 06:02.
MedCity News
DECEMBER 13, 2022
Nearly all patients treated with the Novartis drug iptacopan achieved the hemoglobin goals of pivotal study compared to zero patients who received the AstraZeneca drugs that are the standard of care in a rare blood disorder. The results were presented Tuesday during the annual meeting of the American Society of Hematology.
European Pharmaceutical Review
DECEMBER 13, 2022
North American psychedelic drug developers Mindset, PharmAla, Mydecine and Psyence have signed with clinical research organisation (CRO) Clerkenwell Health to trial therapies for mental health conditions, in London, UK, to benefit from the country’s swift drug regulatory process. The mental health conditions that the companies aim to treat include social anxiety, Autism Spectrum Disorder (ASD), nicotine addiction, major depressive disorder (MDD), and Adjustment Disorder in those facing a termina
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
DECEMBER 13, 2022
Remaining at or near the top of employers’ and consumers’ choices when it comes to health coverage will require insurers to make large investments in infrastructure, processes and people to overcome the status quo.
European Pharmaceutical Review
DECEMBER 13, 2022
The World Health Organization (WHO) linked this recent incident to an Indian manufacturer, saying that the cough syrups contained “unacceptable amounts of diethylene glycol and ethylene glycol” The recent headlines linking the deaths of nearly 70 children in Gambia to diethylene glycol and ethylene glycol (DEG and EG, respectively) poisoning in a paediatric cough syrup, caused disbelief in many quarters.
MedCity News
DECEMBER 13, 2022
One technology that has tremendous potential to both broaden and improve access to preventive healthcare is wearable biosensing — more specifically, the continuous, non-invasive monitoring of multiple biomarkers from a smartwatch or wristband.
European Pharmaceutical Review
DECEMBER 13, 2022
GSK have announced that its global headquarters will move from Brentford, West London to its new headquarters in central London in 2024, placing it near the capital’s fast-growing global life sciences hub, Knowledge Quarter and top academic institutions. GSK’s centrally located headquarters. The new site, currently known as the Earnshaw, is under construction and scheduled for completion in 2023.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharma Pathway
DECEMBER 13, 2022
Alembic Pharmaceuticals Ltd-Walk-In Interviews for Production/ Packing/ Quality Control/ Quality Assurance/ AMV/ Microbiology On 18th Dec’ 2022. Job Description. Alembic Pharmaceuticals Ltd. is an Indian multinational Pharmaceutical company headquartered in Vadodara city of Gujarat-India. Alembic pharmaceuticals Ltd. is involved in manufacture of pharmaceutical products, pharmaceutical substances and Intermediates.
PharmaVoice
DECEMBER 13, 2022
As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.
European Pharmaceutical Review
DECEMBER 13, 2022
Included in this issue of European Pharmaceutical Review : . FOREWORD. The lingering menace of diethylene glycol / ethylene glycol adulteration. David Elder (David P Elder Consultancy). SUSTAINABILITY. Building CO 2 -neutral, defossilised supply chains for organic chemicals. Stefan Koenig, Martin Olbrich and Jan Backmann, Roche. Martin Held, Institute of Biotechnology of the Swiss Federal Institute of Technology.
pharmaphorum
DECEMBER 13, 2022
A new initiative to boost research and development into rare and paediatric diseases launched last week, on Thursday 8 th December, at the European Health Summit. The Rare Disease Moonshot is a collaborative commitment between seven organisations, seeking to break down barriers to finding new treatments and cures for some of the world’s rarest and most severe conditions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharma Pathway
DECEMBER 13, 2022
Tirupati Group – Walk-In Interviews for Production/ Quality Assurance/ Quality Control On 18th Dec’ 2022. Job Description. Tirupati Group- Walk-In Interviews for Production/ Quality Assurance/ Quality Control On 18th Dec’ 2022. Departments: Production/ Quality Assurance/ Quality Control. Qualification: B.Pharm/ M.Pharm/ B.Sc/ M.Sc/ ITI.
Copyright Clearance Center
DECEMBER 13, 2022
The post The Women’s Edge and The Boston Globe Again Name CCC to Top 100 Women-Led Businesses in Massachusetts appeared first on Copyright Clearance Center.
MedReps
DECEMBER 13, 2022
Doctors are inevitably busy people. They have a lot of different things going on, from patient care to keeping up on studies to ensure their approach is top-notch. Depending on the location, some also handle things like staffing, which takes up a large chunk of their time. For these reasons, as well as plenty of others, medical sales reps need to adhere to three main fundamentals when pitching their products to doctors.
Pharma Pathway
DECEMBER 13, 2022
Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC On 14th Dec’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatmen
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaTimes
DECEMBER 13, 2022
DETERMINE trial aims to discover if current treatments could benefit patients with other cancer types
Pharma Pathway
DECEMBER 13, 2022
Glenmark Lifesciences Limited-Walk-In Interview for Production/ Stores On 17th Dec’ 2022. Job Description. We require young energetic professionals of our API plant at Ankleshwar, Dist.- Bharuch, Gujarat. Department: Production/ Stores -API. Designation: Officer/ Senior Officer. Qualification: M.Sc/ B.Sc/ Diploma/ B.E/ B.Com/ M.Com. Experience: 02 to 08 years.
Copyright Clearance Center
DECEMBER 13, 2022
The post Welcoming a New Chef in the Kitchen, Roy Kaufman appeared first on Copyright Clearance Center.
Pharma Pathway
DECEMBER 13, 2022
Vasant Chemicals Pvt. Ltd-Walk-In Interviews for Production/ Pilot Plant On 16th Dec’ 2022. Job Description. Walk-In Interviews for Production/ Pilot Plant On 16th Dec’ 2022 @ Vasant Chemicals Pvt. Ltd. Department: Production/ Pilot Plant. Designation: Chemist/ Sr. Chemist/ Officer/ Engineer/ Sr. Engineer. Qualification: B.Sc/ M.Sc/ B.Tech/ Diploma.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content